메뉴 건너뛰기




Volumn 34, Issue 4, 2003, Pages 381-384

Distribution of monoclonal antiferritin antibody in Kaposi's sarcoma, Hodgkin's disease, and hepatocellular carcinoma

Author keywords

Antiferrtin antibody; Ferritin; Hepatocellular carcinoma; Hodgkin's disease; Kaposi's sarcoma

Indexed keywords

FERRITIN; FERRITIN ANTIBODY; MONOCLONAL ANTIBODY;

EID: 0037739806     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.62     Document Type: Article
Times cited : (2)

References (9)
  • 3
    • 0025825174 scopus 로고
    • Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01
    • Vriesendorp HM, Herpst JM, Germack MA, et al: Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01. J Clin Oncol 9:918-928, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 918-928
    • Vriesendorp, H.M.1    Herpst, J.M.2    Germack, M.A.3
  • 4
    • 0022340257 scopus 로고
    • Iodine-131 antiferritin, a new treatment modality in hepatoma: A Radiation Therapy Oncology Group study
    • Order SE, Stillwagon GB, Klein JL, et al: Iodine-131 antiferritin, a new treatment modality in hepatoma: A Radiation Therapy Oncology Group study. J Clin Oncol 3:1573-1582, 1985
    • (1985) J Clin Oncol , vol.3 , pp. 1573-1582
    • Order, S.E.1    Stillwagon, G.B.2    Klein, J.L.3
  • 5
    • 0025853270 scopus 로고
    • A randomized prospective trial comparing full-dose chemotherapy to 1311 antiferritin: An RTOG study
    • Order S, Pajak T, Leibel S, et al: A randomized prospective trial comparing full-dose chemotherapy to 1311 antiferritin: An RTOG study. Int J Radiat Oncol Biol Phys 20:953-963, 1991
    • (1991) Int J Radiat Oncol Biol Phys , vol.20 , pp. 953-963
    • Order, S.1    Pajak, T.2    Leibel, S.3
  • 6
    • 0032723746 scopus 로고    scopus 로고
    • Fractionated radiolabeled antiferritin therapy for patients with recurrent Hodgkin's disease
    • Vriesendorp HM, Quadri SM, Wyllie CT, et al: Fractionated radiolabeled antiferritin therapy for patients with recurrent Hodgkin's disease. Clin Cancer Res 5(suppl 10):S3324-S3329, 1999
    • (1999) Clin Cancer Res , vol.5 , Issue.SUPPL. 10
    • Vriesendorp, H.M.1    Quadri, S.M.2    Wyllie, C.T.3
  • 7
    • 0022452004 scopus 로고
    • Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars
    • Bindl JM, Warnke RA: Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol 85:490-493, 1986
    • (1986) Am J Clin Pathol , vol.85 , pp. 490-493
    • Bindl, J.M.1    Warnke, R.A.2
  • 8
    • 0028185766 scopus 로고
    • Iron and ferritin in inflammation and cancer
    • Torti SV, Torti FM: Iron and ferritin in inflammation and cancer. Adv Inorg Biochem 10:119-137, 1994
    • (1994) Adv Inorg Biochem , vol.10 , pp. 119-137
    • Torti, S.V.1    Torti, F.M.2
  • 9
    • 0024350384 scopus 로고
    • Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma
    • Klein JL, Nguyen TH, Laroque P, et al: Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma. Cancer Res 49:6383-6389, 1989
    • (1989) Cancer Res , vol.49 , pp. 6383-6389
    • Klein, J.L.1    Nguyen, T.H.2    Laroque, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.